Medidata, a Dassault Systemes company, recently announced a partnership with Lambda Therapeutics. Lambda Therapeutics is a Clinical Research Organization (CRO) based in Ahmedabad, India and provides full-spectrum clinical trial solutions. The collaboration will enable Lambda Therapeutics to implement Medidata’s cloud-based clinical solutions to automate and streamline data management workflows for greater clinical trial efficiency and improved data quality.
The clinical solutions include Rave EDC, Rave RTSM, and Rave Imaging which have been tailored to meet the needs of Lambda Therapeutics. The unified platform will save time and resources while streamlining workflows and minimize risk as well as maintaining data integrity. Rave Imaging leverages advanced machine learning algorithms to provide an intelligent workflow which simplifies image and data collection and de-identification on upload. This simplifies workflows by cutting the time and costs associated with image management while delivering higher data quality.
Bindi Chudgar of Lambda Therapeutics illustrated that the partnership with Medidata will enhance and strengthen clinical trial timelines as well as the competitive advantage of Lambda Therapeutics across the globe. Edwin Ng from Medidata’s Asia Pacific sector highlighted the importance of AI and cloud-enabled solutions for clinical trial efficiency and expediting treatments and devices to market.
Lambda Therapeutics provides an extensive range of services which includes Phase 2 to 4 late-phase clinical efficacy and safety patient-based trials, early phase development, NCE trials, large molecule biosimilar assay development labs, data management, drug safety and pharmacovigilance and medical imaging. The organization has more than 20 years of experience, facilities and operations in North America (the USA and Canada) and Europe (London, and Warsaw, Poland).
Dassault Systemes, the 3DEXPERIENCE Company, is leading the digital transformation of life sciences in the age of personalized medicine with its first end-to-end scientific and business platform. Medidata, which is a wholly-owned subsidiary of Dassault Systemes, leads the digital transformation of life sciences, creating new hope for millions of patients. The platform is trusted by 2,100+ customers and partners, providing access to the world’s most reliable platform for clinical development, commercial and real-world data with over one million registered users.
The person mentioned in this article is Bindi Chudgar, the Founder and Managing Director of Lambda Therapeutics. She is responsible for the overall success and development of Lambda Therapeutics across the globe. Edwin Ng is the Senior Vice President, Asia Pacific, Life Science at Dassault Systemes. The company mentioned in this article is Dassault Systemes, the 3DEXPERIENCE Company, which is leading the digital transformation of life sciences. The company provides business and people with collaborative 3D virtual environments to imagine sustainable innovations. Dassault Systemes brings value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries.
